Many payers are not familiar with digital therapeutics, indicating the need for better education among payers, said Jayne Hornung, chief clinical officer, pharmacy, MMIT.
Many payers are not familiar with digital therapeutics, indicating the need for better education among payers, said Jayne Hornung, chief clinical officer, pharmacy, MMIT.
Transcript
What sorts of education efforts with payers need to be made as more prescription digital therapeutics enter the market?
The Digital Therapeutics Alliance is an organization that their main focus is to educate payers on digital therapeutics, and that has to happen broadly, nationally across all payers. We learned during our survey of payers that many of them were not familiar at all with these digital therapeutics—the names did not ring a bell at all. So, the more we can educate payers on these therapeutics and how they can help the patients, that's what we need to do.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More